After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Catalyst Pharmaceuticals Inc is $3.00B. A total of 0.94 million shares were traded on the day, compared to an average of 1.33M shares.
In the most recent transaction, INGENITO GARY sold 180,096 shares of CPRX for 21.67 per share on Mar 06 ’25. After the transaction, the Chief Med. & Reg. Officer now owns 68,873 company shares. In a previous transaction on Mar 05 ’25, INGENITO GARY sold 44,904 shares at 22.09 per share. CPRX shares that Chief Med. & Reg. Officer owns now total 68,873.
Among the insiders who bought shares, INGENITO GARY acquired of 180,096 shares on Mar 06 ’25 at a per-share price of $21.67. In another insider transaction, Elsbernd Brian sold 62,975 shares at $22.98 per share on Mar 03 ’25. Company shares held by the Chief Compliance/Legal Officer now total 188,564.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CPRX has a high of $26.16 and a low of $14.47.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CPRX’s latest balance sheet shows that the firm has $191.27M in Cash & Short Term Investments as of fiscal 2021. There were $4.20M in debt and $27.06M in liabilities at the time. Its Book Value Per Share was $6.02, while its Total Shareholder’s Equity was $206.83M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CPRX is Buy with a score of 5.00.
